Dull Tasks Tougher on the Entitled
MONDAY, Oct. 10 (HealthDay News) -- People with a sense of
entitlement are more likely to view dull tasks as a waste of their
time, which makes it feel like time is passing slowly while they do
Shift Workers Show Rise in Stress Hormone
MONDAY, Oct. 10 (HealthDay News) -- Shift work or working odd
hours can cause changes in stress hormone levels, especially when
people start these schedules as young adults, according to a new
Everyday Stigma May Take Toll on Lesbians, Gays
MONDAY, Oct. 10 (HealthDay News) -- The stigma and inequalities
that lesbian, gay and bisexual people face on a daily basis can
increase their stress level and affect their well-being, according
to a new study.
Washing the Body 'Cleanses' the Mind
MONDAY, Oct. 10 (HealthDay News) -- There may be some truth to
the expression "cleanliness is next to godliness" after all, finds
a new review of previously published studies.
Chocolate Could Be Sweet Defense Against Stroke
MONDAY, Oct. 10 (HealthDay News) -- In the latest research to
tout the cardiovascular benefits of an already beloved food,
Swedish scientists report that eating chocolate seems to lower a
woman's risk of stroke.
Children's Chest Pain Rarely Cause for Alarm: Study
MONDAY, Oct. 10 (HealthDay News) -- Chest pains that send
children to health clinics are usually triggered by strained
muscles, asthma, or even spicy pizza, and rarely by what parents
fear most -- a life-threatening heart condition, a pediatric study
Dietary Supplements May Harm Older Women: Study
MONDAY, Oct. 10 (HealthDay News) -- Far from being healthy,
supplements such as multivitamins, minerals and folic acid may
actually raise the odds for death in older women who take them, a
new study suggests.
Restless Legs Syndrome May Boost Blood Pressure
MONDAY, Oct. 10 (HealthDay News) -- Middle-aged women who suffer
from a common condition called restless legs syndrome may be at
increased risk of high blood pressure, U.S. researchers report.
New Alzheimer's Drug Shows Early Promise
MONDAY, Oct. 10 (HealthDay News) -- An experimental Alzheimer's
disease drug, gantenerumab, may help lower levels of amyloid plaque
in the brains of people with the disease, an early clinical trial